Literature DB >> 19009326

Altered heart rate control in response to postural change in patients with Machado-Joseph disease (SCA3).

Yu Koyama1, Masato Asahina, Koiti Honma, Kimihito Arai, Takamichi Hattori.   

Abstract

To assess heart rate (HR) regulation in Machado-Joseph disease (MJD), we evaluated HR variability at rest and the initial HR response to standing suddenly in 13 MJD patients and 26 normal control subjects. A head-up tilt (HUT) test involving the monitoring of blood pressure, HR, and cerebral oxy/deoxyhemoglobin concentration was also performed in each participant. There was no significant difference in HR variability at rest between the two groups, but the transient HR rise just after standing suddenly in the MJD group was significantly less than that in the control group (p < 0.01). The HUT test, where each participant was gradually tilted upward, induced a significantly greater HR increase in the MJD group compared with the controls (p < 0.01), while there were no significant differences in the blood pressure and cerebral oxygenation changes between the two groups. In our MJD study, the transient HR rise just after standing suddenly was diminished, and HR markedly increased during sustained orthostatic stress.

Entities:  

Mesh:

Year:  2009        PMID: 19009326     DOI: 10.1007/s12311-008-0076-2

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  15 in total

1.  Involvement of the cerebral cortex and autonomic ganglia in Machado-Joseph disease.

Authors:  M Yamada; S Hayashi; S Tsuji; H Takahashi
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

2.  Cardiovascular autonomic nervous response to postural change in 610 healthy Japanese subjects in relation to age.

Authors:  Yujiro Yamanaka; Koichi Honma
Journal:  Auton Neurosci       Date:  2006-02-08       Impact factor: 3.145

3.  Spectrum of orthostatic disorders: classification based on an analysis of the short-term circulatory response upon standing.

Authors:  W Wieling; A D ten Harkel; J J van Lieshout
Journal:  Clin Sci (Lond)       Date:  1991-08       Impact factor: 6.124

4.  Cardiovascular regulation in the period preceding vasovagal syncope in conscious humans.

Authors:  P O O Julu; V L Cooper; S Hansen; R Hainsworth
Journal:  J Physiol       Date:  2003-04-04       Impact factor: 5.182

Review 5.  Epidemiology and clinical aspects of Machado-Joseph disease.

Authors:  J Sequeiros; P Coutinho
Journal:  Adv Neurol       Date:  1993

6.  Autonomic dysfunction in Machado-Joseph disease.

Authors:  Tu-Hsueh Yeh; Chin-Song Lu; Yah-Huei Wu Chou; Chok-Chean Chong; Tony Wu; Nai-Hui Han; Rou-Shayn Chen
Journal:  Arch Neurol       Date:  2005-04

7.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

8.  Spectral and time-domain analyses of heart-rate variability during head-upright tilt-table testing in children with neurally mediated syncope.

Authors:  Harun Evrengul; Vedide Tavli; Havva Evrengul; Talat Tavli; Dursun Dursunoglu
Journal:  Pediatr Cardiol       Date:  2006-10-27       Impact factor: 1.655

9.  Spinocerebellar ataxias type 1, 2 and 3: a study of heart rate variability.

Authors:  C Pradhan; B S Yashavantha; P K Pal; T N Sathyaprabha
Journal:  Acta Neurol Scand       Date:  2007-11-19       Impact factor: 3.209

10.  Lower urinary tract dysfunction in Machado-Joseph disease: a study of 11 clinical-urodynamic observations.

Authors:  Ryuji Sakakibara; Tomoyuki Uchiyama; Kimihito Arai; Tomonori Yamanishi; Takamichi Hattori
Journal:  J Neurol Sci       Date:  2004-03-15       Impact factor: 3.181

View more
  1 in total

1.  Dysautonomia is frequent in Machado-Joseph disease: clinical and neurophysiological evaluation.

Authors:  Karen A G Takazaki; Anelyssa D'Abreu; Anamarli Nucci; Iscia Lopes-Cendes; Marcondes C França
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.